SPA
OGN icon

Sherbrooke Park Advisers’s Organon & Co OGN Stock Holding History

Sherbrooke Park Advisers’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,711
Closed -$413K – 841
2024
Q4 		$413K Sell
27,711
-543
-2% -$8.85K 0.13% 278
2024
Q3 		$540K Buy
+28,254
New +$586K 0.12% 280

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.96B AUM 38.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sherbrooke Park Advisers's OGN Position: Q1 2025 in Review

Sherbrooke Park Advisers sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 27,711 shares — an estimated $413K sold.

Sherbrooke Park Advisers first reported a position in OGN in Q3 2024 and held it in 2 quarters. The position peaked at $540K in Q3 2024. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Sherbrooke Park Advisers reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 27,711 Organon & Co shares in Q1 2025, an estimated $413K.
  • Sherbrooke Park Advisers first reported a position in Organon & Co in Q3 2024 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Organon & Co position peaked at $540K in Q3 2024.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q1 2025, filed 15 May 2025.